Biologics Characterization

Product Description
SGS

-
US
-
2015On CPHI since
Categories
SGS

-
US
-
2015On CPHI since
More Products from SGS (4)
-
Product Biologics Characterization Services
As a pioneer of physicochemical characterization, we offer you unrivaled expertise in protein analysis. Our laboratories helped to develop mass spectrometry (MS) mapping of biotechnology products, together with other mass spectrometry strategies related to protein/glycoprotein analysis, which have become s... -
Product Extractables & Leachables Testing
The assessment of Extractables and Leachables in bio/pharmaceutical products is an important step in drug product development. Processing equipment, as well as, primary and secondary container closures are potential vectors for chemical contaminants. Monomers and polymer additives such as antioxidants, pla... -
Product Quality Control Testing
Analytical chemistry services from SGS provide you with the bio/pharmaceutical expertise and regulatory qualifications to perform the necessary raw material testing, and testing on APIs, finished products, packaging material and medical devices. -
Product Analytical Chemistry
SGS provides the professional expertise and regulatory qualifications necessary to perform analytical testing of raw materials, APIs, finished products, packaging material and medical devices. Well-equipped state-of-the-art laboratories offer comprehensive testing services according to the pharmacopoei...
SGS resources (9)
-
News SGS joins with Biophytis to launch international trial of COVID-19 related respiratory failure treatment
The CRO will undertake this clinical trial at multiple sites worldwide, starting at the AZ Sint Maarten hospital in Mechelen, Belgium. -
Brochure Bioanalysis Testing Solutions
With over 30 years of experience and operating out of our GLP/GCP compliant laboratories. SGS has the expertise to both develop assays from scratch (including LC-MS/MS, immunoassays and cell-based assays) and to support large scale routine sample analyses, from regulatory pre-clinical (toxicology) to early and late clinical studies (Phase I to IV).
-
News OneVision: Creating a Global Standardized Laboratory Network for SGS Life Sciences
SGS launches OneVision, a global digitalization initiative to standardize record-keeping procedures across all Life Sciences’ testing laboratories.
-
Whitepaper DETECTION OF MYCOPLASMA IN BIOPHARMACEUTICALS VACCINES AND GENE CELL THERAPIES
Mycoplasma are a form of bacteria that are characterized by the absence of a cell wall surrounding the cell membrane. This renders them inert to many familiar antibiotics, including the beta-lactams, whose activity relies on cell wall disruption. Many different mycoplasma are pathogenic in humans, and they are also commonly found as contaminants in cell cultures. Although the contamination does not create turbidity, factors such as cell line growth rates and viral vaccine production can be adversely affected. This clearly poses a problem for processes that involve cell culture, and thus, being able to detect them is important.
-
News SGS Expands Extractables and Leachables Testing Capabilities at its Shanghai Facility
SGS has significantly increased its capabilities to undertake extractables and leachables (E&L) testing at its Shanghai, China, laboratory. -
News SGS Celebrates the Opening of the Biologics Testing Facility expansion in Glasgow
SGS has celebrated the official opening of the Biologics, Viral Vaccine, Gene and Cell Therapy Testing facility expansion in Glasgow, UK in May. The newly extended state-of-the-art facility now doubles the total floor space from 1,200 m2 to 2,400 m2. -
News SGS implements Veeva Vault clinical trial management system across its global network
Will improve operational efficiency and drive faster, higher-quality trial execution. -
News SGS Appoints Biologics Manager at Facility in Illinois
SGS, a leading bio/pharmaceutical analytical and bioanalytical contract solutions provider, today announced the appointment of Dr. Haris Jamil as Biologics Manager of its recently expanded biopharmaceutical testing facility in Lincolnshire, Illinois, USA. -
News SGS to expand bioanalytical testing capabilities
The €3.5 million investment in equipment, facilities and expert staff will significantly increase the capabilities at the site to match increasing demand and shorten processes for pharmaceutical clients.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance